期刊文献+

左金丸联合西药治疗胃食管反流病58例 被引量:5

Clinical Observation on 58 Cases of Gestroesophageal Reflux Disease Treated with Zuojin Pill and Western Medicine
下载PDF
导出
摘要 目的观察左金丸加味联合西药治疗胃食管反流病(GERD)临床疗效。方法 114例患者随机分为2组,对照组(56例)给予口服兰索拉唑片及马来酸曲美布汀片治疗,治疗组(58例)在服用上述西药基础上配合左金丸加味治疗,观察其疗效。结果治疗组总有效率96.55%,对照组总有效率78.57%,2组疗效有明显差异(χ2=8.55,P<0.01)。结论中西医结合组治疗胃食管反流病疗效明显优于西药组。 Objective To observe the clinical effect of the combined therapy of modified Zuojin Wart and western medicine for the treatment of gastroesophageal reflux disease. Methods 114 patients were randomized into two groups. The control group (56) was given Lansoprazole and Trimebutine Maleate tablets. The therapeutic group (58) was administered with modified Zuojin Wan besides the above mentioned western medicine. The effects of the two groups were observed. Results The total effective rate of the therapeutic group was 96.55%, and that of the control group was 78.57%. The difference was significant ((2 =8.55, P 〈 0.01). Conclusion The effect of the integrated traditional Chinese and western medicine therapy group was obviously better than that of the western medicine group.
作者 魏晓 田丰华
出处 《中国中医药现代远程教育》 2012年第4期45-46,共2页 Chinese Medicine Modern Distance Education of China
关键词 左金丸 胃食管反流病 中西医结合疗法 临床观察 Modified Zuojin Wan Gastroesophageal reflux disease (GERD) Integrated traditional Chinese and western medicine Clinical observation
  • 相关文献

参考文献4

二级参考文献23

  • 1Huang X,Zhu HM,Deng CZ,Porro GB,Sangaletti O,Pace F.Gastroesophageal reflux: the features in elderlypatients[J].World Journal of Gastroenterology,1999,5(5):421-423. 被引量:13
  • 2孙永顺,朱生梁,马淑颖,邓玉海.260例胃食管反流病中医证候特点剖析[J].江苏中医药,2004,25(12):11-12. 被引量:30
  • 3高萍,许国铭,邹多武.50名正常中国成人食管24小时pH监测结果分析[J].中华消化杂志,1996,16(1):32-34. 被引量:103
  • 4张文彤.SPSS11统计分析教程(高级篇)[M].北京:北京希望电子出版社,2002.300-310.
  • 5Lundel L R,Dent J,Bennett JR,et al, Endoseopie assessment of oesop hagitis:clinical and functional correlates and further validation of the Los Angeles classification[J],Gut, 1999,45(2) : 172-180.
  • 6Goh KL. “On-demand”therapy for gastroesophageal reflux disease: Are current proton pump inhibitors good candidates? J Gastroenterol Hepatol, 2006, 21(Suppl 5) :S115-S118.
  • 7Cheung TK, Wong BC. Proton-pump inhibitor failure/resistance: Proposed mechanisms and therapeutic algorithm. J Gastroenterol Hepatol, 2006, 21(Suppl 5):S119-S124.
  • 8Hallerback B, Unge P, Carling L, et al. Omeprazole or raniti-dine in long-term treatment of reflux esophagitis. Gastro-enterology,1994,107:1305-1311.
  • 9Dent J,Yeomans N, Mackinnon M,et al. Omeprazole vs. rani tidine for prevention of relapse in reflux oesophagitis. A controlled double-blind trial of their efficacy and safety. Gut, 1994,35:590-598.
  • 10Ang TL,Fock KM. Nocturnal acid breakthrough:Clinical significance and management. J Gastroenterol Hepatol, 2006,21(Suppl 5): S125-S128.

共引文献232

同被引文献138

引证文献5

二级引证文献130

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部